Project Profile
Share QR code

Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age with Untreated High Risk (Secondary) AML

Developed by The Clearinghouse for Applied Research
© 1999-2024, State of Florida
About
Discover
Connect
Disclaimer of Liability | Privacy Policy

Back to top

Keyword Search

Please enter valid search criteria.
Search
University

Browse by STEM

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences
Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation